The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 38 | — | 20.1x | Near average | |
Growth | 73 | — | 5.6% | Above average | |
Quality | 11 | -104.1% | 7.6% | Below average | |
Safety | 29 | 1.7x | 0.4x | Below average | |
Capital Return | 20 | 0.00% | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
PepGen Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy PepGen Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
PepGen stock shows complete stability in the average price target at 5.5 dollars over the past thirty days, with a consensus from 3 analysts. Despite the significant gap between the current price (1.51 dollars) and the lowest price target (4 dollars), the absence of any recent price revisions indicates a state of anticipation awaiting clinical results or tangible financial data, especially with continued expectations of losses in earnings per share (EPS) for the coming periods.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.